Cogent Biosciences Inc (COGT) — Cash Flow Reinvestment Rate

Latest as of December 2015: 0.11x

Cogent Biosciences Inc (COGT) has a Cash Flow Reinvestment Rate of 0.11x as of December 2015, reinvesting $1.99 Million (capex $1.99 Million ) from operating cash flow of $17.72 Million. Explore how much does Cogent Biosciences Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.11x
(Capex + Investments) / Operating CF

Total Reinvested

$1.99 Million
Capex + Investments

Operating Cash Flow

$17.72 Million
USD

Capital Expenditures

$1.99 Million
USD

Cogent Biosciences Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Cogent Biosciences Inc across 1 annual periods. Also explore COGT total asset value for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Cogent Biosciences Inc (2015–2015)

Year-by-year capital reinvestment analysis for Cogent Biosciences Inc. For live market cap and broader valuation context, see Cogent Biosciences Inc stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.11x $1.99 Million $17.72 Million $1.99 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow